Oswald, Willaim
Browning, Craig
Yasmin, Ruthba
Deal, Joshua
Rich, Thomas C.
Leavesley, Silas J.
Gong, Na
Funding for this research was provided by:
NSF (MMRI1725937)
NSF (CNS1953544)
NSF (OIA2218046)
NSF (OISE1951488)
Alabama EPSCoR Graduate Research Fellowship
NIH (P01HL066299)
NIH (S10OD028606)
Alabama Space Grant Consortium
Article History
Received: 12 October 2023
Accepted: 14 June 2024
First Online: 26 June 2024
Competing interests
: Drs. Leavesley and Rich disclose financial interest in a start-up company, SpectraCyte LLC, which was formed to commercialize spectral imaging technologies.